Factors associated with upgrading to malignancy at surgery of atypical ductal hyperplasia diagnosed on core biopsy

Breast

Volumn 20, Issue 1, 2011, Pages 50-55

  Deshaies, Isabelle ^a,b   Provencher, Louise ^a,b   Jacob, Simon ^a,b   Côté, Gary ^a,b   Robert, Jean ^a,b   Desbiens, Christine ^a,b   Poirier, Brigitte ^a,b   Hogue, Jean Charles ^a   Vachon, Éric ^a   Diorio, Caroline ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

Atypical ductal hyperplasia; Carcinoma; Core needle biopsy; Underestimation; Upgrading rate; Vacuum assisted biopsy

Indexed keywords

ADULT; AGED; ARTICLE; BREAST BIOPSY; BREAST CALCIFICATION; BREAST CARCINOMA; BREAST HYPERPLASIA; BREAST PAPILLOMA; BREAST SURGERY; CANCER INVASION; CONTROLLED STUDY; DISEASE SEVERITY; FACTORIAL ANALYSIS; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; MAMMOGRAPHY; NEEDLE BIOPSY; PRIORITY JOURNAL; SYMPTOM;

EID: 79451469966     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.breast.2010.06.004     Document Type: Article

References (53)

1. Adepoju L.J., Symmans W.F., Babiera G.V., Singletary S.E., Arun B., Sneige N., et al. Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy. Cancer 2006, 106:42-50.
2. Collins L.C., Baer H.J., Tamimi R.M., Connolly J.L., Colditz G.A., Schnitt S.J. Magnitude and laterality of breast cancer risk according to histologic type of atypical hyperplasia: results from the Nurses' Health Study. Cancer 2007, 109:180-187.
3. Degnim A.C., Visscher D.W., Berman H.K., Frost M.H., Sellers T.A., Vierkant R.A., et al. Stratification of breast cancer risk in women with atypia: a Mayo cohort study. J Clin Oncol 2007, 25:2671-2677.
4. Worsham M.J., Abrams J., Raju U., Kapke A., Lu M., Cheng J., et al. Breast cancer incidence in a cohort of women with benign breast disease from a multiethnic, primary health care population. Breast J 2007, 13:115-121.
5. Dupont W.D., Page D.L. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 1985, 312:146-151.
6. Tavassoli F.A., Norris H.J. A comparison of the results of long-term follow-up for atypical intraductal hyperplasia and intraductal hyperplasia of the breast. Cancer 1990, 65:518-529.
7. Sloane J.P., Amendoeira I., Apostolikas N., Bellocq J.P., Bianchi S., Boecker W., et al. Consistency achieved by 23 European pathologists from 12 countries in diagnosing breast disease and reporting prognostic features of carcinomas. European Commission Working Group on Breast Screening Pathology. Virchows Arch 1999, 434:3-10.
8. Ghofrani M., Tapia B., Tavassoli F.A. Discrepancies in the diagnosis of intraductal proliferative lesions of the breast and its management implications: results of a multinational survey. Virchows Arch 2006, 449:609-616.
9. Liberman L., Dershaw D.D., Glassman J.R., Abramson A.F., Morris E.A., LaTrenta L.R., et al. Analysis of cancers not diagnosed at stereotactic core breast biopsy. Radiology 1997, 203:151-157.
10. Chae B.J., Lee A., Song B.J., Jung S.S. Predictive factors for breast cancer in patients diagnosed atypical ductal hyperplasia at core needle biopsy. World J Surg Oncol 2009, 7:77.
11. Wagoner M.J., Laronga C., Acs G. Extent and histologic pattern of atypical ductal hyperplasia present on core needle biopsy specimens of the breast can predict ductal carcinoma in situ in subsequent excision. Am J Clin Pathol 2009, 131:112-121.
12. Forgeard C., Benchaib M., Guerin N., Thiesse P., Mignotte, Faure C., et al. Is surgical biopsy mandatory in case of atypical ductal hyperplasia on 11-gauge core needle biopsy? A retrospective study of 300 patients. Am J Surg 2008, 196:339-345.
13. Ko E., Han W., Lee J.W., Cho J., Kim E.K., Jung S.Y., et al. Scoring system for predicting malignancy in patients diagnosed with atypical ductal hyperplasia at ultrasound-guided core needle biopsy. Breast Cancer Res Treat 2008, 112:189-195.
14. Page D.L., Dupont W.D., Rogers L.W., Rados M.S. Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer 1985, 55:2698-2708.
15. Page D.L., Rogers L.W. Combined histologic and cytologic criteria for the diagnosis of mammary atypical ductal hyperplasia. Hum Pathol 1992, 23:1095-1097.
16. Schnitt S.J., Collins L.C. Biopsy interpretation of the breast 2009, Lippincott Williams & Wilkins, Philadelphia, PA.
17. Sohn V., Arthurs Z., Herbert G., Keylock J., Perry J., Eckert M., et al. Atypical ductal hyperplasia: improved accuracy with the 11-gauge vacuum-assisted versus the 14-gauge core biopsy needle. Ann Surg Oncol 2007, 14:2497-2501.
18. Jang M., Cho N., Moon W.K., Park J.S., Seong M.H., Park I.A. Underestimation of atypical ductal hyperplasia at sonographically guided core biopsy of the breast. AJR Am J Roentgenol 2008, 191:1347-1351.
19. Adrales G., Turk P., Wallace T., Bird R., Norton H.J., Greene F. Is surgical excision necessary for atypical ductal hyperplasia of the breast diagnosed by mammotome?. Am J Surg 2000, 180:313-315.
20. Jackman R.J., Birdwell R.L., Ikeda D.M. Atypical ductal hyperplasia: can some lesions be defined as probably benign after stereotactic 11-gauge vacuum-assisted biopsy, eliminating the recommendation for surgical excision?. Radiology 2002, 224:548-554.
21. Liberman L., Holland A.E., Marjan D., Murray M.P., Bartella L., Morris E.A., et al. Underestimation of atypical ductal hyperplasia at MRI-guided 9-gauge vacuum-assisted breast biopsy. AJR Am J Roentgenol 2007, 188:684-690.
22. Jackman R.J., Burbank F., Parker S.H., Evans W.P., Lechner M.C., Richardson T.R., et al. Atypical ductal hyperplasia diagnosed at stereotactic breast biopsy: improved reliability with 14-gauge, directional, vacuum-assisted biopsy. Radiology 1997, 204:485-488.
23. Eby P.R., Ochsner J.E., DeMartini W.B., Allison K.H., Peacock S., Lehman C.D. Frequency and upgrade rates of atypical ductal hyperplasia diagnosed at stereotactic vacuum-assisted breast biopsy: 9-versus 11-gauge. AJR Am J Roentgenol 2009, 192:229-234.
24. Eby P.R., Ochsner J.E., DeMartini W.B., Allison K.H., Peacock S., Lehman C.D. Is surgical excision necessary for focal atypical ductal hyperplasia found at stereotactic vacuum-assisted breast biopsy?. Ann Surg Oncol 2008, 15:3232-3238.
25. Graesslin O., Antoine M., Chopier J., Seror J.Y., Flahault A., Callard P., et al. Histology after lumpectomy in women with epithelial atypia on stereotactic vacuum-assisted breast biopsy. Eur J Surg Oncol 2010, 36:170-175.
26. Philpotts L.E., Lee C.H., Horvath L.J., Lange R.C., Carter D., Tocino I. Underestimation of breast cancer with II-gauge vacuum suction biopsy. AJR Am J Roentgenol 2000, 175:1047-1050.
27. Dupont W.D., Parl F.F., Hartmann W.H., Brinton L.A., Winfield A.C., Worrell J.A., et al. Breast cancer risk associated with proliferative breast disease and atypical hyperplasia. Cancer 1993, 71:1258-1265.
28. Agoff S.N., Lawton T.J. Papillary lesions of the breast with and without atypical ductal hyperplasia: can we accurately predict benign behavior from core needle biopsy?. Am J Clin Pathol 2004, 122:440-443.
29. Lewis J.T., Hartmann L.C., Vierkant R.A., Maloney S.D., Shane Pankratz V., Allers T.M., et al. An analysis of breast cancer risk in women with single, multiple, and atypical papilloma. Am J Surg Pathol 2006, 30:665-672.
30. Page D.L., Kidd T.E., Dupont W.D., Simpson J.F., Rogers L.W. Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease. Hum Pathol 1991, 22:1232-1239.
31. Chuba P.J., Hamre M.R., Yap J., Severson R.K., Lucas D., Shamsa F., et al. Bilateral risk for subsequent breast cancer after lobular carcinoma-in-situ: analysis of surveillance, epidemiology, and end results data. J Clin Oncol 2005, 23:5534-5541.
32. Fajardo L.L., Pisano E.D., Caudry D.J., Gatsonis C.A., Berg W.A., Connolly J., et al. Stereotactic and sonographic large-core biopsy of nonpalpable breast lesions: results of the Radiologic Diagnostic Oncology Group V study. Acad Radiol 2004, 11:293-308.
33. Darling M.L., Smith D.N., Lester S.C., Kaelin C., Selland D.L., Denison C.M., et al. Atypical ductal hyperplasia and ductal carcinoma in situ as revealed by large-core needle breast biopsy: results of surgical excision. AJR Am J Roentgenol 2000, 175:1341-1346.
34. Willett W.C., Rockhill B., Hankinson S.E., Hunter D., Colditz G.A. Nongenetic factors in the causation of breast cancer. Diseases of the breast 2004, 223-276. Lippincott, Williams & Wilkins, Philadelphia. 3rd ed. J.R.L. Harris, M.E. Lippman, M. Morrow, C.K. Osborne (Eds.).
35. Ely K.A., Carter B.A., Jensen R.A., Simpson J.F., Page D.L. Core biopsy of the breast with atypical ductal hyperplasia: a probabilistic approach to reporting. Am J Surg Pathol 2001, 25:1017-1021.
36. Sneige N., Lim S.C., Whitman G.J., Krishnamurthy S., Sahin A.A., Smith T.L., et al. Atypical ductal hyperplasia diagnosis by directional vacuum-assisted stereotactic biopsy of breast microcalcifications. Considerations for surgical excision. Am J Clin Pathol 2003, 119:248-253.
37. Yeh I.T., Dimitrov D., Otto P., Miller A.R., Kahlenberg M.S., Cruz A. Pathologic review of atypical hyperplasia identified by image-guided breast needle core biopsy. Correlation with excision specimen. Arch Pathol Lab Med 2003, 127:49-54.
38. Fuhrman G.M., Cederbom G.J., Bolton J.S., King T.A., Duncan J.L., Champaign J.L., et al. Image-guided core-needle breast biopsy is an accurate technique to evaluate patients with nonpalpable imaging abnormalities. Ann Surg 1998, 227:932-939.
39. Lin P.H., Clyde J.C., Bates D.M., Garcia J.M., Matsumoto G.H., Girvin G.W. Accuracy of stereotactic core-needle breast biopsy in atypical ductal hyperplasia. Am J Surg 1998, 175:380-382.
40. Gadzala D.E., Cederbom G.J., Bolton J.S., McKinnon W.M., Farr G.H., Champaign J., et al. Appropriate management of atypical ductal hyperplasia diagnosed by stereotactic core needle breast biopsy. Ann Surg Oncol 1997, 4:283-286.
41. Moore M.M., Hargett C.W., Hanks J.B., Fajardo L.L., Harvey J.A., Frierson H.F., et al. Association of breast cancer with the finding of atypical ductal hyperplasia at core breast biopsy. Ann Surg 1997, 225:726-731. discussion 731-723.
42. Meyer J.E., Smith D.N., Lester S.C., Kaelin C., DiPiro P.J., Denison CM., et al. Large-core needle biopsy of nonpalpable breast lesions. JAMA 1999, 281:1638-1641.
43. Houssami N., Ciatto S., Ellis I., Ambrogetti D. Underestimation of malignancy of breast core-needle biopsy: concepts and precise overall and category-specific estimates. Cancer 2007, 109:487-495.
44. Zhao L., Freimanis R., Bergman S., Shen P., Perrier N.D., Lesko N., et al. Biopsy needle technique and the accuracy of diagnosis of atypical ductal hyperplasia for mammographic abnormalities. Am Surg 2003, 69:757-762. discussion 762.
45. Lourenco A.P., Mainiero M.B., Lazarus E., Giri D., Schepps B. Stereotactic breast biopsy: comparison of histologic underestimation rates with 11- and 9-gauge vacuum-assisted breast biopsy. AJR Am J Roentgenol 2007, 189:W275-W279.
46. Ingegnoli A., d'Aloia C., Frattaruolo A., Pallavera L., Martella E., Crisi G., et al. Flat epithelial atypia and atypical ductal hyperplasia: carcinoma underestimation rate. Breast J 2010, 16:55-59.
47. Teng-Swan Ho J., Tan P.H., Hee S.W., Su-Lin Wong J. Underestimation of malignancy of atypical ductal hyperplasia diagnosed on 11-gauge stereotactically guided mammotome breast biopsy: an asian breast screen experience. Breast 2008, 17:401-406.
48. Travade A., Isnard A., Bouchet F., Bagard C. Non-palpable breast lesions and core needle biopsy with mammotome 11G: is surgery required in patients with atypical ductal hyperplasia?. J Radiol 2006, 87:307-310.
49. Winchester D.J., Bernstein J.R., Jeske J.M., Nicholson M.H., Hahn E.A., Goldschmidt R.A., et al. Upstaging of atypical ductal hyperplasia after vacuum-assisted 11-gauge stereotactic core needle biopsy. Arch Surg 2003, 138:619-622. discussion 622-613.
50. Gal-Gombos E.C., Esserman L.E., Recine M.A., Poppiti R.J. Large-needle core biopsy in atypical intraductal epithelial hyperplasia including immunohistochemical expression of high molecular weight cytokeratin: analysis of results of a single institution. Breast J 2002, 8:269-274.
51. Burak W.E., Owens K.E., Tighe M.B., Kemp L., Dinges S.A., Hitchcock C.L., et al. Vacuum-assisted stereotactic breast biopsy: histologic underestimation of malignant lesions. Arch Surg 2000, 135:700-703.
52. Cangiarella J., Waisman J., Symmans W.F., Gross J., Cohen J.M., Wu H., et al. Mammotome core biopsy for mammary microcalcification: analysis of 160 biopsies from 142 women with surgical and radiologic followup. Cancer 2001, 91:173-177.
53. Brem R.F., Behrndt V.S., Sanow L., Gatewood O.M. Atypical ductal hyperplasia: histologic underestimation of carcinoma in tissue harvested from impalpable breast lesions using 11-gauge stereotactically guided directional vacuum-assisted biopsy. AJR Am J Roentgenol 1999, 172:1405-1407.